Overview

For more than 30 years, Hillel has been a key adviser to leading Canadian and foreign companies on their transactional matters.

Clients in diverse sectors, including life sciences and commercial real estate, value his thorough understanding of their businesses, his responsiveness and his pragmatic approach to challenging and time-sensitive transactions.

Hillel is recognized for both his corporate commercial law expertise as well for his command of life sciences transactions. An exceptional corporate lawyer, he is sought out by both domestic and multinational players.

Hillel has been a long-time counsel to several of Canada’s leading specialty pharmaceutical companies.

Acted for the shareholders of Searchlight Pharma Inc., a top-growth Canadian specialty and innovative branded pharmaceutical company, in connection with the sale of their 100% interest to Apotex Inc.

Acted for The Cadillac Fairview Corporation Limited with respect to the establishment of a joint venture for the development of Tour des Canadiens 2, a 49 storey residential condominium building located across from the Bell Centre in the heart of downtown Montréal and represented the joint venture, Tour des Canadiens 2 S.E.C., in connection with that development. Davies also represented The Cadillac Fairview Corporation Limited in the establishment of a joint venture in the development of Tour des Canadiens 3, a 55-storey residential condominium building, and acted for the joint venture, Tour des Canadiens 3 S.E.C., in that development.

Acted for Knight Therapeutics International S.A. in negotiating a complex supply and distribution agreement with Eton Pharmaceuticals granting exclusive U.S. commercialization rights for IMPAVIDO, the only FDA-approved oral treatment for certain forms of leishmaniasis.

University of Oxford, MA, 1987 McGill University, BCL/LLB (Double Gold Medallist), 1985

Practice Areas

• Banking/Finance
• Corporate & Commercial Law
• Real Estate

Bar Information

Called to the bar: 1988 (QC)